AU2002307822A1 - Generation of monoclonal antibodies to poorly immunogenic antigens expressed or carried by eukaryotic cells, use of monoclonal antibodies for therapeutical, diagnostic or vaccine applications - Google Patents

Generation of monoclonal antibodies to poorly immunogenic antigens expressed or carried by eukaryotic cells, use of monoclonal antibodies for therapeutical, diagnostic or vaccine applications

Info

Publication number
AU2002307822A1
AU2002307822A1 AU2002307822A AU2002307822A AU2002307822A1 AU 2002307822 A1 AU2002307822 A1 AU 2002307822A1 AU 2002307822 A AU2002307822 A AU 2002307822A AU 2002307822 A AU2002307822 A AU 2002307822A AU 2002307822 A1 AU2002307822 A1 AU 2002307822A1
Authority
AU
Australia
Prior art keywords
monoclonal antibodies
therapeutical
diagnostic
generation
carried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002307822A
Inventor
Jurg Gysin
Artur Scherf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2002307822A1 publication Critical patent/AU2002307822A1/en
Abandoned legal-status Critical Current

Links

AU2002307822A 2001-02-23 2002-02-22 Generation of monoclonal antibodies to poorly immunogenic antigens expressed or carried by eukaryotic cells, use of monoclonal antibodies for therapeutical, diagnostic or vaccine applications Abandoned AU2002307822A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/270,581 2001-02-23

Publications (1)

Publication Number Publication Date
AU2002307822A1 true AU2002307822A1 (en) 2002-09-04

Family

ID=

Similar Documents

Publication Publication Date Title
WO2005012479A3 (en) Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
MXPA02005639A (en) Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions.
HUP0004327A3 (en) Fusion proteins containing human papilloma virus (hpv) proteins and immunological fusion partner with t-helper epitopes to the hpv antigen, as well as vaccine formulations for treatment and/or profilaxis of hpv induced lesions
WO1999033868A3 (en) Human papillomavirus vaccine
EP1568373A3 (en) Inducing cellular immune responses to HER2/neu using peptide and nucleic acid compositions
MY137299A (en) Neutralizing high affinity human monoclonal antibodies specific to rsv f-protein and methods for their manufacture and therapeutic use thereof
AU2342897A (en) Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
NZ527283A (en) Modified antibodies and methods of use
DK1292328T3 (en) Chimeric human papillomavirus (HPV) molecules and their use
BRPI0412245A (en) rg1 antibodies and uses of these
WO2008057235A3 (en) Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
WO2002102299A3 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
AU2003246373A8 (en) Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
WO2002036790A3 (en) Influenza virus vector for infection of dendritic cells
WO2006050219A3 (en) Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies
WO2001090151A3 (en) Human receptor proteins; related reagents and methods
AU2002221519A1 (en) Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
AU2003294120A1 (en) Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies
AU2003302235A1 (en) Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof
IL144265A0 (en) Use of antibodies for the vaccination against cancer
AU2002307822A1 (en) Generation of monoclonal antibodies to poorly immunogenic antigens expressed or carried by eukaryotic cells, use of monoclonal antibodies for therapeutical, diagnostic or vaccine applications
WO2002060390A3 (en) Induction of immune responses to isoaspartyl-modified antigens
WO2009137632A3 (en) Hiv immunogen and method of making and using same
WO2007020243A3 (en) Vaccine based on virus-neutralizing antibodies
AU2001280256A1 (en) Methods for the diagnosis and/or treatment of diseases related to anti-phospholipid antibodies and devices used therein